Image

Global ELISpot and FluoroSpot Assay Market – Industry Trends and Forecast to 2031

Medical Devices

Image

Global ELISpot and FluoroSpot Assay Market – Industry Trends and Forecast to 2031

  • Medical Devices
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global ELISpot and FluoroSpot Assay Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 301.25 Million
Diagram Market Size (Forecast Year) USD 784.00 Million
Diagram CAGR %

Global ELISpot and FluoroSpot Assay Market, By Product Type (Assay Kits, Analysers, Supplementary Or Ancillary Products), By Source (Human, Mouse, Monkey And Others), Diseases (Infectious Diseases, Cancer, Autoimmune Diseases, Allergy And Others), Application (Diagnostic Applications, Research Applications,), End User (Hospitals and Clinical Laboratories, Research Institutes, Biopharmaceutical Companies And Others), Distribution (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2031.

 ELISpot and FluoroSpot Assay Market

ELISpot and FluoroSpot Assay Market Analysis and Size

The enzyme-linked immunospot (ELISpot) assay, known for its high sensitivity, is extensively employed for diagnosing diverse diseases. Its flexibility is evident in measuring antigen-specific T cells in both mice and humans. Increasingly popular, ELISpot is preferred for its ability to assess a broad spectrum of immune responses and cellular activities. This transformation has propelled ELISpot from a research tool to a widely adopted clinical assay, prominently utilized in laboratories for comprehensive disease diagnostics.

Data Bridge Market Research analyses that the global ELISpot and FluoroSpot assay market which was USD 301.25 million in 2023, is expected to reach USD 784.00 million by 2031, and is expected to undergo a CAGR of 12.7% during the forecast period of 2024 to 2031.This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

ELISpot and FluoroSpot Assay Market Scope and Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Assay Kits, Analysers, Supplementary Or Ancillary Products), By Source (Human, Mouse, Monkey And Others), Diseases (Infectious Diseases, Cancer, Autoimmune Diseases, Allergy And Others), Application (Diagnostic Applications, Research Applications,), End User (Hospitals and Clinical Laboratories, Research Institutes, Biopharmaceutical Companies And Others), Distribution (Direct Tender, Retail Sales)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Oxford Immunotec USA, Inc.(U.S.), BD (U.S.), R&D Systems, Inc.(U.S.), Mabtech (Sweden), Thermo Fischer Scientific (U.S.), Covalab, Inc. (France), Oxford BioSystems (U.K.), AUTOIMMUN DIAGNOSTIKA GMBH (Germany), Abcam Limited (U.K.), Labcorp Drug Development (U.S.), Cellular Technology Limited (U.S.), U-CyTech (Netherlands) Bio-Techne (U.S.), MIKROGEN GmbH. (Germany)

Market Opportunities

  • Growth of biopharmaceutical industry
  • Increasing number of healthcare and pharmaceutical facilities globally
  • Rising research and development opportunities

Market Definition

Enzyme-linked immunospot (ELISpot) and FluoroSpot assays are immunological techniques used to quantify specific immune responses at the single-cell level. ELISpot detects secreted proteins, typically cytokines, from individual cells, providing insight into cellular immune activity. FluoroSpot extends this by incorporating fluorescent detection, allowing simultaneous assessment of multiple analytes. These assays are crucial in immunology research and clinical diagnostics, aiding in understanding and monitoring immune responses.

Global ELISpot and FluoroSpot Assay Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases

The ELISpot and FluoroSpot assays, offering precise quantification at the single-cell level, are instrumental in disease diagnosis, treatment monitoring, and vaccine development. With a surge in global chronic diseases, these immunological assays have become crucial for understanding and monitoring immune responses linked to chronic conditions. As a result, the healthcare sector experiences growing demand for these technologies, marking them as essential tools in advancing medical research and diagnostics.

  • Rising demand in disease diagnostics

The ELISpot and FluoroSpot assay market is propelled by a rising demand for accurate diagnostics in infectious diseases, autoimmune disorders, and cancer. These assays offer single-cell level insights into immune responses, enabling clinicians and researchers to diagnose and monitor diseases with precision. As the importance of personalized and targeted therapies grows, the market for ELISpot and FluoroSpot assays continues to expand to meet the evolving requirements of disease diagnostics.

Opportunities

  • Rise in immunology research

The escalating research focus in immunology, spanning infectious diseases, cancer, and autoimmune disorders, presents a significant opportunity for the ELISpot and FluoroSpot assay market. As these assays play a pivotal role in understanding immune responses, the surge in immunology research acts as a catalyst, driving increased demand and adoption in both research and clinical applications.

  • Expanding applications

The diverse applications of ELISpot and FluoroSpot assays, ranging from vaccine development to monitoring treatment effectiveness and personalized medicine, present a significant opportunity for market expansion. As these assays prove instrumental across various medical domains, their versatile utility positions them as crucial tools for advancing research and diagnostics in healthcare.

Restraints/Challenges

  • High costs

High costs associated with initial setup and reagent expenses create a significant barrier to the widespread adoption of ELISpot and FluoroSpot assays, particularly in resource-constrained settings. This financial constraint limits accessibility and hampers the market's growth, impeding the integration of these valuable immunological techniques in diverse research and diagnostic applications.

  • Skill-Dependent Technique

The ELISpot and FluoroSpot assays are challenged by their skill-dependent nature, demanding specialized expertise for accurate execution. This dependence on skilled personnel may hinder the broader adoption of these assays, limiting accessibility and potentially impacting the consistency and reliability of results across diverse laboratory settings.

This global ELISpot and FluoroSpot assay market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global ELISpot and FluoroSpot assay market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In June 2022, BD and CerTest Biotec joined forces to develop a molecular diagnostic test for Monkeypox virus, a rare ailment linked to smallpox. Utilizing BD MAX open system reagents, the collaboration validates CerTest VIASURE Monkeypox CE/IVD molecular test on the BD MAX System. This aims to enhance Monkeypox diagnosis, management, and contribute to global disease spread insights
  • In April 2022, ProImmune Ltd. introduced a B-cell ELISpot assay service, a method for analyzing B cell immune responses crucial for defense against infections and therapeutic interventions. Researchers can gauge vaccine efficacy or drug potency by quantifying B cells producing specific antibodies in response to stimuli, enhancing assessments of immunological interventions
  • In April 2021, BD's participation in virtual investor healthcare conferences, including "The Bank of America Securities 2021 Virtual Healthcare Conference" and "The UBS Global Healthcare Virtual Conference," facilitated global visibility. This strategic engagement likely attracted new customers and contributed to enhanced future market revenue for the company

Global ELISpot and FluoroSpot Assay Market Scope

The global ELISpot and FluoroSpot assay market is segmented on the basis of product type, source, diseases, applications, end user and distribution. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Assay Kits
  • Analysers
  • Supplementary or Ancillary Products

 Source

  • Human
  • Mouse
  • Monkey
  • Others

 Diseases

  • Infectious Diseases
  • Cancer
  • Autoimmune Diseases
  • Allergy
  • Others

 Application 

  • Diagnostic Applications
  • Research Applications

 End User

  • Hospitals and Clinical Laboratories
  • Research Institutes
  • Biopharmaceutical Companies
  • Others

Distribution

  • Direct Tender
  • Retail Sales

Global ELISpot and FluoroSpot Assay Market Regional Analysis/Insights

The global ELISpot and FluoroSpot assay market is analysed and market size insights and trends are provided by country product type, source, diseases, applications, end user and distribution as referenced above.

The countries covered in the global ELISpot and FluoroSpot assay market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the ELISpot and FluoroSpot assay market, driven by its largest consumer market, high GDP, and increased technological advancements. The region's prominence is further accentuated by the rise of infectious chronic diseases and the presence of major market players, solidifying its leadership in advancing immunological research and diagnostics.  

Asia-Pacific is expected to witness significant growth in the ELISpot and FluoroSpot assay market from 2024 to 2031. This surge is driven by the rise in immunology research, advancements in technology, expanding applications, and the growth of the biopharmaceutical industry, reflecting the region's increasing prominence in driving advancements in immunological assays.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global ELISpot and FluoroSpot assay market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global ELISpot and FluoroSpot assay market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global ELISpot and FluoroSpot assay market. The data is available for historic period 2016-2021.

Competitive Landscape and Global ELISpot and FluoroSpot Assay Market Share Analysis

The global ELISpot and FluoroSpot assay market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global ELISpot and FluoroSpot assay market.

Some of the major players operating in the global ELISpot and FluoroSpot assay market are:

  • Oxford Immunotec USA, Inc.(U.S.)
  •  BD (U.S.)
  •  R&D Systems, Inc. (U.S.)
  • Mabtech (Sweden)
  • Thermo Fischer Scientific (U.S.)
  •  Covalab, Inc. (France)
  •  Oxford BioSystems (U.K.)
  •  AUTOIMMUN DIAGNOSTIKA GMBH (Germany)
  •  Abcam Limited (U.K.)
  •  Labcorp Drug Development (U.S.)
  •  Cellular Technology Limited  (U.S.)
  •  U-CyTech (Netherlands)
  • Bio-Techne (U.S.)
  •  MIKROGEN GmbH. (Germany)

  


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The global ELISpot and FluoroSpot assay market value was USD 301.25 million in 2023.
The growth rate of the ELISpot and FluoroSpot assay market is 12.7% during the forecast by 2031.
The increasing prevalence of chronic diseases the rising demand in disease diagnostics are the growth drivers of the sulfate of potash market.
Product type, source, diseases, applications, end user and distribution are the factors on which the sulfate of potash market research is based.
Major companies in the cancer immunotherapy market are Oxford Immunotec USA, Inc.(U.S.), BD (U.S.), R&D Systems, Inc.(U.S.), Mabtech (Sweden), Thermo Fischer Scientific (U.S.), Covalab, Inc. (France), Oxford BioSystems (U.K.), AUTOIMMUN DIAGNOSTIKA GMBH (Germany), Abcam Limited (U.K.), Labcorp Drug Development (U.S.), Cellular Technology Limited (U.S.), U-CyTech (Netherlands) Bio-Techne (U.S.), MIKROGEN GmbH. (Germany).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials